Press Releases Dynavax Technologies Corporation

Equities

DVAX

US2681582019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
12.06 ^USD	-1.71%		+0.58%	-13.73%

May. 24	Dynavax Technologies Corporation Reappoints Ernst & Young LLP as Independent Registered Public Accounting Firm	CI
May. 14	Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dynavax to Present at Upcoming Investor Conferences	May. 28	PR
Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.	May. 14	PR
Dynavax Technologies: Q1 Earnings Snapshot	May. 08	AQ
Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates	May. 08	PR
Dynavax Technologies : Additional proxy soliciting material – supplement	Apr. 29	PU
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	Apr. 24	PR
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference	Feb. 27	PR
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance	Feb. 22	PR
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024	Feb. 08	PR
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights	Jan. 08	PR
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	PR
Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference	Nov. 20	PR
Dynavax Technologies: Q3 Earnings Snapshot	Nov. 02	AQ
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance	Nov. 02	PR
Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023	23-10-26	PR
Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference	23-10-19	PR
Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-06	PR
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance	23-08-03	PR
Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023	23-07-20	PR
Dynavax to Present at Upcoming Investor Conferences	23-05-30	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Dynavax Technologies Corporation

Equities

DVAX

US2681582019

Press Releases

Filters